Abstract | OBJECTIVE: DESIGN: The mean values (+/- 1 SD) of ST segment shifts on the surface and intracoronary electrocardiograms were measured at the end of the first and second balloon inflations, both 2 min long. The severity of cardiac pain was obtained at the same time using a visual analogue scale. RESULTS: In bamiphylline-treated patients, the mean ST segment shift and the severity of cardiac pain during the second inflation were similar to those during the first inflation (14 +/- 15 vs 16 +/- 16 mm, ns and 31 +/- 28 vs 31 +/- 29, ns, respectively). Conversely, in placebo-treated patients both the mean ST segment shift and the severity of cardiac pain during the second inflation were significantly less than those during the first inflation (10 +/- 6 vs 17 +/- 7 mm, P < 0.001 and 25 +/- 21 vs 39 +/- 31 mm, P < 0.01, respectively). Thus, bamiphylline abolishes ischaemic preconditioning observed in man during repeated coronary balloon inflations. CONCLUSION: These results suggest that, in this setting, ischaemic preconditioning is mediated, at least in part, by A1 adenosine receptors.
|
Authors | F Tomai, F Crea, A Gaspardone, F Versaci, R De Paulis, P Polisca, L Chiariello, P A Gioffrè |
Journal | European heart journal
(Eur Heart J)
Vol. 17
Issue 6
Pg. 846-53
(Jun 1996)
ISSN: 0195-668X [Print] England |
PMID | 8781823
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Receptors, Purinergic P1
- Vasodilator Agents
- Theophylline
- bamifylline
|
Topics |
- Adult
- Aged
- Analysis of Variance
- Angioplasty, Balloon, Coronary
- Coronary Disease
(therapy)
- Double-Blind Method
- Female
- Humans
- Infusions, Intravenous
- Ischemic Preconditioning, Myocardial
- Male
- Middle Aged
- Pain Measurement
- Receptors, Purinergic P1
(drug effects)
- Theophylline
(administration & dosage, analogs & derivatives, therapeutic use)
- Treatment Outcome
- Vasodilator Agents
(administration & dosage, therapeutic use)
|